ASTRAZENECA (NASDAQ: AZN) reported Q1 2022 earnings per share (EPS) of $0.13, up 78.99% year over year. Total ASTRAZENECA earnings for the quarter were $386.00 million. In the same quarter last year, ASTRAZENECA's earnings per share (EPS) was $0.60.
What was AZN's earnings growth in the past year?
As of Q2 2022, ASTRAZENECA's earnings has grown null year over year. ASTRAZENECA's earnings in the past year totalled -$1.06 billion.
What was AZN's revenue last quarter?
ASTRAZENECA (NASDAQ: AZN) reported Q1 2022 revenue of $11.39 billion up 55.6% year over year. In the same quarter last year, ASTRAZENECA's revenue was $7.32 billion.
What was AZN's revenue growth in the past year?
As of Q2 2022, ASTRAZENECA's revenue has grown 50.41% year over year. This is 25.68 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 24.73%. ASTRAZENECA's revenue in the past year totalled $41.49 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.